Abstract

Hepatocellular carcinoma (HCC) has the second highest mortality rate worldwide among all cancers. Previous studies have revealed the significant involvement of long noncoding RNAs (lncRNAs) in numerous human cancers including HCC. Both oncogenic and tumor repressive lncRNAs have been identified and implicated in the complex process of hepatocarcinogenesis. They can be further explored as prospective diagnostic, prognostic, and therapeutic markers for HCC. An in-depth understanding of lncRNAs' mechanism in HCC is therefore required to fully explore their potential role. In the current review, we will concentrate on the underlying function, molecular mechanisms, and potential clinical implications of lncRNA in HCC.

Highlights

  • Among all cancers, hepatocellular carcinoma (HCC) has the second highest mortality rate worldwide [1]

  • It is vital to illustrate the molecular mechanism of HCC in order to improve diagnosis, treatment, and overall prognosis

  • The long ncRNAs with more than 200 nucleotides play significant roles in cell growth and differentiation, chromatin organization, and regulation of gene expression [7, 8]. lncRNAs are classified into intronic, intergenic, sense, and antisense types based on their genomic location [9] and into signaling, decoy, guide, and scaffold lncRNAs on a functional basis [10]

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) has the second highest mortality rate worldwide [1]. HOTAIR enhances proliferation, migration, glycolysis, autophagy, and chemoresistance in HCC cells (Table 1). FOXC1 upregulated HOTAIR in HCC cells via miR-1 inhibition, thereby increasing proliferation [30].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call